Oscotec Inc.
Seongnam-si, KR· latest recorded location
Oscotec Inc. is named on 17 US grants and 19 published applications in this corpus. Its most frequent classification is A61P (Therapeutic uses of medicines).
- Granted patents
- 17
- Published applications
- 19
- Inventors
- 62
- Granted in 2026 so far
- 0
- Most recent grant
- 8 Jul 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 1 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 1 |
| 2008 | 0 | 5 |
| 2009 | 2 | 0 |
| 2010 | 2 | 3 |
| 2011 | 2 | 2 |
| 2012 | 2 | 1 |
| 2013 | 1 | 2 |
| 2014 | 3 | 0 |
| 2015 | 1 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 1 | 0 |
| 2023 | 1 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
| 2026 | 0 | 2 |
By publication year. 2026 runs to 8 Oct.
Technology areas
Share of 36 documents
- A61PTherapeutic uses of medicines32
- A61KMedicines and medical preparations30
- C07DHeterocyclic compounds16
- A61LMethods or apparatus for sterilising materials or objects in general3
- C07BGeneral methods of organic chemistry2
- C07CAcyclic or carbocyclic compounds2
- A21DTreatment of flour or dough for baking1
- A23LFoods, foodstuffs or non-alcoholic beverages, not otherwise provided for1
- A23VIndexing scheme relating to foods, foodstuffs or non-alcoholic beverages and lactic or1
- C01BNon-metallic elements1
Recent patents
- Pyridopyrimidinone derivatives for use as AXL inhibitors8 Jul 2025US 12,350,272 B2
- Crystal polymorph of 8-bromo-2-(1-methylpiperidin-4-ylamino)-4-(4-phenoxyphenylamino)pyrido[4,3-d]pyrimidin-5(6H)-one hydrochloride and method for preparing same22 Aug 2023US 11,731,969 B2
- Substituted pyrazoles as LRRK2 inhibitors28 Jun 2022US 11,370,796 B2
- Substituted pyrimidine compounds and their use as SYK inhibitors15 Dec 2015US 9,212,178 B2
- Substituted pyridopyrimidine compounds and their use as FLT3 inhibitors4 Nov 2014US 8,877,763 B2
- Crystalline forms of spleen tyrosine kinase inhibitor ski-o-70316 Jul 2026US 2026/0200907 A1
- Fusion comprising anti-tau antibody and peptide and use thereof16 Jul 2026US 2026/0201024 A1
- Pyrrolo(pyrazolo)pyrimidine derivative as lrrk2 inhibitor25 Nov 2021US 2021/0363144 A1
- Substituted pyrimidine compounds and their use as syk inhibitors23 Apr 2015US 2015/0111883 A1
- Substituted pyrimidine compounds and their use as syk inhibitors17 Oct 2013US 2013/0274242 A1
Most cited
By later US patents
- Method for preparation of the supersaturated solution of calcium phosphate and the thin film of calcium phosphate crystal by using the solution10US 6,720,023 B12004
- Kinase inhibitors8US 8,629,132 B22014
- Herbal mixture extract of notoginseng radix, rehmanniae radix preparata and acanthopanacis cortex and composition comprising the same for prevention and treatment of arthritis7US 7,811,612 B22010
- Kinase inhibitors4US 8,404,677 B22013
- Substituted pyrimidine compounds and their use as SYK inhibitors4US 8,871,778 B22014